InvestorsHub Logo
Followers 10
Posts 1064
Boards Moderated 0
Alias Born 11/24/2007

Re: jmkobers post# 13398

Sunday, 04/19/2015 4:13:48 PM

Sunday, April 19, 2015 4:13:48 PM

Post# of 20689
Current stock price suggests market expects that they will sell glatopa in September and MYL will get its drug approved. But I see 2 potential upsides : one they win the patent case with a timely decision and MYL on their CC states that they need to rework the ANDA. Worse case scenario is launching in September with 2 generics still a big pie to share.